TriSalus Life Sciences, Inc. (TLSIW) Operating income 2021–2025
TriSalus Life Sciences, Inc. (TLSIW) annual operating income history from SEC filings — each fiscal year as reported.
-$26.9MFY2025 · since FY2021: -$3.0M → -$26.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$26.9M | +25.5% |
| FY2024 | -$36.2M | +33.6% |
| FY2023 | -$54.5M | -49.5% |
| FY2022 | -$36.4M | -1098.4% |
| FY2021 | -$3.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TLSIW financial trends
TLSIW RevenueTLSIW Net incomeTLSIW Net marginTLSIW Gross profitTLSIW Gross marginTLSIW Operating marginTLSIW Operating cash flowTLSIW Free cash flowTLSIW Capital expendituresTLSIW Return on equityTLSIW Stock buybacksTLSIW Dividends paidTLSIW Total assetsTLSIW Total liabilitiesTLSIW Shareholders’ equityTLSIW overview →